Patents Assigned to Tacit Therapeutics, Inc.
  • RNA EDITING VIA RECRUITMENT OF SPLICEOSOME COMPONENTS
    Publication number: 20250051764
    Abstract: Disclosed are methods and compositions for promoting trans-splicing. In some embodiments, the composition comprises an engineered small nuclear RNA that promotes trans-splicing of a target RNA molecule. The composition may further comprise an RNA donor molecule.
    Type: Application
    Filed: October 10, 2024
    Publication date: February 13, 2025
    Applicant: Tacit Therapeutics, Inc.
    Inventor: David A. NELLES
  • RNA editing via recruitment of spliceosome components
    Patent number: 12152239
    Abstract: Disclosed are methods and compositions for promoting trans-splicing. In some embodiments, the composition comprises an engineered small nuclear RNA that promotes trans-splicing of a target RNA molecule. The composition may further comprise an RNA donor molecule.
    Type: Grant
    Filed: July 31, 2023
    Date of Patent: November 26, 2024
    Assignee: Tacit Therapeutics, Inc.
    Inventor: David A. Nelles